106 related articles for article (PubMed ID: 6113769)
1. Breast cancer in hospitalized psychiatric patients.
Goode DJ; Corbett WT; Schey HM; Suh SH; Woodie B; Morris DL; Morrisey L
Am J Psychiatry; 1981 Jun; 138(6):804-6. PubMed ID: 6113769
[TBL] [Abstract][Full Text] [Related]
2. Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
Froes Brandao D; Strasser-Weippl K; Goss PE
Cancer; 2016 Jan; 122(2):184-8. PubMed ID: 26457577
[TBL] [Abstract][Full Text] [Related]
3. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
4. Prolactin and smoking status in antipsychotic-treated patients.
Mackin P; Waton A; Nulkar A; Watkinson HM
J Psychopharmacol; 2011 May; 25(5):698-703. PubMed ID: 20699354
[TBL] [Abstract][Full Text] [Related]
5. Prolactin response to neuroleptics. Clinical and theoretical implications.
Ohman R; Axelsson R
J Neural Transm Suppl; 1980; 17():1-74. PubMed ID: 6133911
[No Abstract] [Full Text] [Related]
6. Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease.
Lalonde FM; Myslobodsky M
Breast; 2003 Aug; 12(4):280-2. PubMed ID: 14659314
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole prescribing and continuation rates during psychiatric hospitalization.
Coley KC
Ann Pharmacother; 2005; 39(7-8):1367-8. PubMed ID: 15956242
[No Abstract] [Full Text] [Related]
8. Breast and other cancer deaths in a mental hospital.
Costa D; Mesteş E; Coban A
Neoplasma; 1981; 28(3):371-8. PubMed ID: 6117020
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic treatment in breast cancer patients.
Rahman T; Clevenger CV; Kaklamani V; Lauriello J; Campbell A; Malwitz K; Kirkland RS
Am J Psychiatry; 2014 Jun; 171(6):616-21. PubMed ID: 24880509
[TBL] [Abstract][Full Text] [Related]
11. Dopamine antagonists and the development of breast cancer.
Wang PS; Walker AM; Tsuang MT; Orav EJ; Glynn RJ; Levin R; Avorn J
Arch Gen Psychiatry; 2002 Dec; 59(12):1147-54. PubMed ID: 12470131
[TBL] [Abstract][Full Text] [Related]
12. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
Bushe C; Yeomans D; Floyd T; Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):56-62. PubMed ID: 18477621
[TBL] [Abstract][Full Text] [Related]
13. Are chronic psychiatric patients at increased risk for developing breast cancer?
Halbreich U; Shen J; Panaro V
Am J Psychiatry; 1996 Apr; 153(4):559-60. PubMed ID: 8599407
[TBL] [Abstract][Full Text] [Related]
14. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
[TBL] [Abstract][Full Text] [Related]
15. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.
Pope HG; Keck PE; McElroy SL
Am J Psychiatry; 1986 Oct; 143(10):1227-33. PubMed ID: 2876647
[TBL] [Abstract][Full Text] [Related]
16. The effect of long term phenothiazine therapy on plasma prolactin.
Wilson RG; Hamilton JR; Boyd WD; Forrest AP; Cole EN; Boyns AR; Griffiths K
Br J Psychiatry; 1975 Jul; 127():71-4. PubMed ID: 237595
[No Abstract] [Full Text] [Related]
17. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
Sankaranarayanan J; Puumala SE
Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Schyve PM; Smithline F; Meltzer HY
Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and breast cancer risk.
Beumont PJ
Med J Aust; 1991 Feb; 154(3):219. PubMed ID: 1671167
[No Abstract] [Full Text] [Related]
20. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
